Loading insider details...
Beta
Latest Form 4 (Jul 15, 2026): Grant/Award of 14,150 TRAW shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 15, 2026 | Traws Pharma, Inc. (TRAW) | Grant/Award | 14,150 | n/a |
| Mar 10, 2026 | Traws Pharma, Inc. (TRAW) | Grant/Award | 33,435 | n/a |
| Dec 16, 2025 | Traws Pharma, Inc. (TRAW) | Grant/Award | 6,157 | n/a |
| Oct 16, 2025 | Traws Pharma, Inc. (TRAW) | Grant/Award | 11,530 | n/a |
| Jun 23, 2025 | Traws Pharma, Inc. (TRAW) | Grant/Award | 23,000 | n/a |
| Aug 14, 2023 | Onconova Therapeutics, Inc. (ONTX) | Grant/Award | 66,468 | n/a |
| Aug 19, 2022 | Onconova Therapeutics, Inc. (ONTX) | Grant/Award | 66,468 | n/a |
| Jul 30, 2021 | Onconova Therapeutics, Inc. (ONTX) | Grant/Award | 13,000 | n/a |
| Feb 17, 2021 | Onconova Therapeutics, Inc. (ONTX) | Purchase | 13,000 | $13.0K |
| Nov 30, 2020 | Onconova Therapeutics, Inc. (ONTX) | Purchase | 37,735 | $10.0K |